Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer.

Khoogar R, Kim BC, Morris J, Wargovich MJ.

Am J Physiol Gastrointest Liver Physiol. 2016 May 1;310(9):G629-44. doi: 10.1152/ajpgi.00201.2015. Epub 2016 Feb 18. Review.

2.
3.

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.

Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38. Epub 2011 Mar 15.

4.

Primary prevention of colorectal cancer.

Chan AT, Giovannucci EL.

Gastroenterology. 2010 Jun;138(6):2029-2043.e10. doi: 10.1053/j.gastro.2010.01.057. Review.

5.

Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans.

Kim S, Martin C, Galanko J, Woosley JT, Schroeder JC, Keku TO, Satia JA, Halabi S, Sandler RS.

Am J Epidemiol. 2008 Dec 1;168(11):1292-300. doi: 10.1093/aje/kwn255. Epub 2008 Oct 21.

6.

Aspirin dose and duration of use and risk of colorectal cancer in men.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS.

Gastroenterology. 2008 Jan;134(1):21-8. Epub 2007 Sep 26.

7.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

8.

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study.

Sørensen HT, Friis S, Nørgård B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA.

Br J Cancer. 2003 Jun 2;88(11):1687-92.

Supplemental Content

Support Center